Table 2 Baseline patient characteristics.
| Ā | Vancomycin (nā=ā99) | Digoxin (nā=ā25) | Tacrolimus (nā=ā35) |
|---|---|---|---|
Age, median (range) | 58 (2ā84) | 77 (37ā100) | 41 (1ā72) |
Sex (male/female) | 59/40 | 12/13 | 23/12 |
Outpatient/inpatient | 1/98 | 8/17 | 17/18 |
Disease, n (%) | |||
| Ā | Valvular heart disease, 27 (27.3%) | Heart failure,7 (28%) | Kidney transplant,12 (34.3%) |
| Ā | Stroke, 7 (7.1) | Valvular heart disease, 3 (12%) | Lung transplant, 6 (17.1%) |
Multiple organ failure, 6(6.1%) | Cardiomyopathy, 3(12%) | Liver transplant, 4 (11.4) | |
Renal failure 5 (5.1%) | Atrial fibrillation 2, (8%) | Nephrotic syndrome, 3 (8.6%) | |
Pneumonia, 5 (5.1%) | Drug intoxication, 2 (8% | Cardiomyopathy 2 (5.7%) | |
| Ā | Other, 49 (49.5%) | Other, 8 (32%) | Other, 8 (22.9%) |
CV episodes (n) | 154 | 37 | 41 |
Ā =ā1 | 124 | 30 | 35 |
Ā ā„ā2 | 30 | 7 | 6 |
CV correction | Ā | Ā | Ā |
Ā Yes | 62 | 21 | 33 |
Ā No or unknown | 37 | 4 | 2 |
Correction time (h) | 24 (5ā331) | 42 (23ā360) | 24 (21ā336) |